Aspire Biopharma Holdings, Inc. Share Price & Technical Analysis
ASBP · $5.46 (-2.33%)
Healthcare / Biotechnology
$5.46
-2.33%
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually admin…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
2600% return in May, -1% avg return in past 3 year May month.
2400% return in 2026, -50% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -62% | -30% | -29% | -80% | 2600% | – | – | – | – | – | – | – | 2400% |
| 25 | 13% | -89% | -65% | -24% | -4% | -35% | 36% | 51% | -63% | 74% | -73% | 26% | -154% |
| 24 | 0% | 1% | 0% | 1% | 1% | 0% | 0% | 0% | 9% | -8% | 0% | 0% | 4% |
| 23 | 1% | 0% | 0% | 0% | -1% | 0% | 1% | 3% | -1% | -2% | -2% | 0% | 0% |
| 22 | – | – | – | 0% | 0% | 0% | 0% | 1% | 1% | 0% | 1% | 0% | 3% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Strong
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$838.19K
P/E ratio
—
52W high
$35.00
52W low
$0.11
Volume
44,418
Beta
0.21
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Aspire Biopharma Holdings, Inc. share price today?
- Aspire Biopharma Holdings, Inc. (ASBP) last traded around $5.46 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ASBP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ASBP. Download the app for real-time alerts.
- How can I analyze Aspire Biopharma Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.